Provided by Tiger Trade Technology Pte. Ltd.

Jasper Therapeutics

0.7160
+0.02483.59%
Post-market: 0.73080.0148+2.06%18:14 EDT
Volume:780.85K
Turnover:546.45K
Market Cap:23.82M
PE:-0.45
High:0.7357
Open:0.6800
Low:0.6750
Close:0.6912
52wk High:3.05
52wk Low:0.3151
Shares:33.27M
Float Shares:30.00M
Volume Ratio:0.65
T/O Rate:2.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5797
EPS(LYR):-3.9545
ROE:-255.05%
ROA:-113.41%
PB:16.86
PE(LYR):-0.18

Loading ...

Feb 17, 2023

Major Issues Report

8-K - Current report
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 30, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Major Issues Report

8-K - Current report
Jan 25, 2023

Major Issues Report

8-K - Current report
Jan 24, 2023

Major Issues Report

8-K - Current report
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Major Issues Report

8-K - Current report
Jan 10, 2023

Major Issues Report

8-K - Current report
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 04, 2022

Major Issues Report

8-K - Current report
Oct 14, 2022

Correspondence

CORRESP [Cover] - Correspondence